Press Resease

Enzyme-linked immunosorbent assay (ELISA) testing Market - Global Industry Analysis

Enzyme-linked immunosorbent assay (ELISA) testing Market by Test type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA) By Application (Immunology, Inflammation, Infectious diseases, Cancer, Protein quantification, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 08-Jun-2021 Category: Pharmaceutical Report Format : PDF Pages: 140 Report Code: ZMR-1978 Status : Published

The global Enzyme-linked immunosorbent assay (ELISA) testing market accounted for USD 513.4 Million in 2020 and is expected to reach USD 725.6 Million by 2028, growing at a CAGR of around 4.4 % between 2021 and 2028.

Description

Market Overview      

The global Enzyme-linked immunosorbent assay (ELISA) testing market accounted for USD 513.4 Million in 2020 and is expected to reach USD 725.6 Million by 2028, growing at a CAGR of around 4.4 % between 2021 and 2028. 

Enzyme linked immunosrbent assay (ELISA) is a test that detects and/or quantifies antibodies in the biological samples. This test can be used to determine if the sample has antibodies related or generated against specific antigen related to the certain infectious condition. Antibodies are proteins that are produced against foreign pathogen as an immunogenic response to harmful substances called pathogen. ELISA is a biochemical reaction in which antigen is adsorbed on a solid surface. An antibody linked to an enzyme is allowed with the antigen and is detected by adding a substrate specific to the linked enzyme. ELISA test plays very important role in the diagnosis of viral infections such as HIV, varicella-zoster virus, which causes chickenpox and shingles, rotavirus, Zika virus, syphilis etc. ELISA is often used as a screening tool before more in-depth tests are carried out. ELISA also can be used in pharmaceutical quality control tests such as endotoxin tests, protein quantification.    

COVID-19 Impact Analysis:

The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.  The significant decrease in the global Enzyme-linked immunosorbent assay (ELISA) testing market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Growth Factors

Global Enzyme-Linked Immunosorbent Assay (ELISA) testing market is primarily driven by the emergence of cost effective technologies and laboratory automation for ELISA assay. Other major driving factors are increasing research and development on biomarkers and monoclonal antibodies (mABs) coupled along with continued growth in drug discovery market. However, the threat of substitution by new technologies such as multiplex proteomic array platforms is the major restraints that may limit the growth of the market. Nonetheless increasing the need for accurate and early disease diagnosis owing to increasing burden of chronic diseases across the globe along with increasing geriatric population base are likely to disclose the new avenues for Enzyme-Linked Immunosorbent Assay (ELISA) testing market in the near future.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is segmented on the basis of different test types such as Test type, indirect ELISA, multiple and portable ELISA and competitive ELISA. Indirect ELISA segment is expected to grow at fastest rate in the global market over the forecast period.

Immunology, inflammation, infectious diseases, cancer, protein quantification and other are the key applications of the global ELISA testing Market. The immunology segment dominated the market in terms of revenue in 2016.

Key Market Players & Competitive Landscape

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global air quality control system market are Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others..

 The global Enzyme-linked immunosorbent assay (ELISA) testing Market is segmented as follows:

By Test type

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and portable ELISA
  • Competitive ELISA

By Applications   

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Test type
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Enzyme-linked immunosorbent assay (ELISA) testing Market – Test type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Test type, 2020 & 2028
    • 4.2. Soil
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Indirect ELISA
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Enzyme-linked immunosorbent assay (ELISA) testing Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Immunulogy
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Inflammation
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Infectious diseases
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Cancer
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Protein quantification
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Construction and Land Development
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.9. Others
      • 5.9.1. Market Size and Forecast, By Region (USD Million)
      • 5.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.2.2. North America Market Revenue, By Test type, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Test type, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Test type, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Test type, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.3.2. Europe Market Revenue, By Test type, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Test type, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Test type, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Test type, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Test type, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Test type, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Test type, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Test type, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Test type, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Test type, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Test type, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Test type, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Test type, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Test type, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Test type, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Test type, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Test type, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Test type, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Test type, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Test type, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Test type, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Test type, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Enzyme-linked immunosorbent assay (ELISA) testing Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Test type Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Company Market Share, 2019
      • 8.1.2. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. GEO Inc
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfulio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Enzyme-linked immunosorbent assay (ELISA) testing Resources Pty Ltd
    • 9.3. Gulder Associates Corporation
    • 9.4. Clean Harbors
    • 9.5. Entact LLC
    • 9.6. Brisea Group, Inc
    • 9.7. Environmental and Marine Engineering NV (Belgium)
    • 9.8. Dredging
    • 9.9. Newterra Ltd
    • 9.10. Terra Systems, Inc.
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodulogy
    • 11.1. Research Methodulogy
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Enzyme-Linked Immunosorbent Assay (ELISA) Testing market. Zion Research has collected and analyzed key data belong to the global Enzyme-Linked Immunosorbent Assay (ELISA) Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Enzyme-Linked Immunosorbent Assay (ELISA) Testing across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Enzyme-Linked Immunosorbent Assay (ELISA) Testing industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Enzyme-Linked Immunosorbent Assay (ELISA) Testing market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Enzyme-Linked Immunosorbent Assay (ELISA) also called enzyme immunoassay (EIA) is a plate based assay technique for detection and quantification of substances such as proteins, hormones, antibodies etc. The ELISA has been used widely as an important diagnostic tool in medicine, plant pathology, as well as a quality-control check in pharmaceutical and biotech industries. ELISA assay technique is based on specific antigen antibody binding. Antigen to be quantified is immobilized (adsorbed) on a solid surface and is complexed with antibody linked to an enzyme. Detection is accomplished by assessing the conjugated enzyme activity via incubation with a substrate to produce a product that can be measured. ELISA has applications in various applications such as allergen detection in the food industry, viral infection diagnosis in the pathology laboratory and in quality control tests in the pharmaceutical industry.

The emergence of cost effective technologies and laboratory automation for ELISA assay is expected to be the major driver for the global ELISA technologies market. In addition, continuous developments in biomarkers and monoclonal antibodies (mABs) coupled along with continued growth in drug discovery market is expected to trigger the growth of global ELISA technologies industry in the coming years. However, the threat of substitution by new technologies such as multiplex proteomic array platforms may pose the challenge to ELISA technologies market. Nevertheless, increasing need for accurate and early disease diagnosis owing to increasing burden of chronic diseases across the globe along with increasing geriatric population base is expected to act as opportunities for ELISA technologies market in near future.

Based on test type, ELISA technologies market has been segmented into sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Indirect ELISA segment is expected to grow at the fastest rate during the forecast period. The ELISA technologies market is segmented based on applications into immunology, inflammation, infectious diseases, cancer, protein quantification and other applications. In terms of revenue, immunology segment dominated the market in 2016.  

North America is expected to remain the dominant region over the forecast period. Increasing healthcare expenditure is expected to boost the market in this region. Europe was the second largest market followed by Asia Pacific. North America is expected to show fastest growth rate during the forecast period while Asia Pacific market is projected to grow at the highest rate during the forecast period. The Middle East and Africa, and Latin America are also expected to experience moderate growth in the years to come.

Some of the key players in ELISA technologies market include Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.

Frequently Asked Questions

The global Enzyme-linked immunosorbent assay (ELISA) testing Market was valued at USD 513.4 Million in 2020.

The global Enzyme-linked immunosorbent assay (ELISA) testing Market is expected to reach USD 725.6 Million by 2028, growing at a CAGR of 4.4% between 2021 to 2028.

Some of the key factors driving the global Enzyme-linked immunosorbent assay (ELISA) testing Market growth are increasing research and development on biomarkers and monoclonal antibodies (mABs) coupled along with continued growth in drug discovery market.  

North America has been leading the worldwide Enzyme-linked immunosorbent assay (ELISA) testing market and is anticipated to continue on the dominant position in the years to come, states the market study.

Some of the major players of global Enzyme-linked immunosorbent assay (ELISA) testing market includes Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

How it Works?

Our Company